# Nebulised 3% Hypertonic Saline Versus 0.9% Saline for Treating Patients Hospitalized With Acute Bronchiolitis

> **NCT06069336** · NA · COMPLETED · sponsor: **Szpital im. Św. Jadwigi Śląskiej** · enrollment: 180 (actual)

## Conditions studied

- Bronchiolitis

## Interventions

- **DRUG:** Hypertonic saline
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT06069336
- **Lead sponsor:** Szpital im. Św. Jadwigi Śląskiej
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-01
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-04-30
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2025-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06069336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06069336, "Nebulised 3% Hypertonic Saline Versus 0.9% Saline for Treating Patients Hospitalized With Acute Bronchiolitis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06069336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*